Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A 44-year-old patient died from
amyotrophic lateral sclerosis
(
ALS
) after nine years of heavy exposure to cadmium (Cd) in a nickel cadmium (Ni-Cd) battery factory. Two years after starting work he and co-workers had experienced pruritus,
loss of smell
, nasal congestion, nosebleeds, cough, shortness of breath, severe headaches, bone pain, and proteinuria. Upper back pain and muscle weakness progressed to flaccid paralysis. EMG findings were consistent with motor neuron disease. Cd impairs the blood-brain barrier, reduces levels of brain copper-zinc (Cu-Zn) superoxide dismutase (SOD), and enhances excitoxicity of glutamate via up-regulation of glutamate dehydrogenase and down-regulation of glutamate uptake in glial cells. High levels of methallothionein, a sign of exposure to heavy metals, have been found in brain tissue of deceased
ALS
patients. The effects of Cd on enzyme systems that mediate neurotoxicity and motor neuron disease suggest a cause effect relationship between Cd and
ALS
in this worker.
...
PMID:Amyotrophic lateral sclerosis in a battery-factory worker exposed to cadmium. 1137 40
We utilized the well-validated University of Pennsylvania Smell Identification Test (UPSIT) to examine whether olfactory dysfunction occurs in
ALS
participants. After adjusting for relevant confounders in a multiple linear regression model,
ALS
participants scored significantly lower on the UPSIT compared with control participants, with an estimated mean difference of 2.31 points (
P
= 0.015).
ALS
participants also had twice the rate of olfactory dysfunction (microsmia or
anosmia
). This study suggests that olfactory dysfunction exists in
ALS
patients, which expands our understanding of the extramotor findings in
ALS
. Future investigations could determine whether there are correlations between olfactory dysfunction and specific
ALS
phenotypes.
...
PMID:Olfactory dysfunction in amyotrophic lateral sclerosis. 3012 22